UK’s MRC Tech licenses antibody to Chinese group
UK medical research charity MRC Technology has licensed an antibody to Newsummit Biopharma, a leading China-based drug development process solutions provider, for development of a novel therapeutic for treatment of Hepatitis C virus infection.
Read More
